Pursuant to Regulation 33 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, please find attached the Unaudited Financial Results for the quarter and half year ended 30-September-2025.
Financial Results For The Quarter And Half Year Ended 30-Sep-2025
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Sudarshan Pharma Industries Ltd on 6ix
Earlier from Sudarshan Pharma Industries
- Sudarshan Pharma Industries Ltd Press Release Oct 15 2025
- Board Meeting Intimation for Approval Of Financial Results For The Quarter And Half Year Ended 30-Sep-2025
- Sudarshan Pharma Industries Ltd Press Release Sep 30 2025
- Closure of Trading Window
- Sudarshan Pharma Industries Ltd Press Release Sep 08 2025
Later from Sudarshan Pharma Industries
- Announcement under Regulation 30 (LODR)-Change in Directorate
- Sudarshan Pharma Industries Ltd Press Release Oct 19 2025
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Sudarshan Pharma Industries Ltd Press Release Oct 20 2025
Follow Sudarshan Pharma Industries into a list and get an email when it puts out news.
Follow Sudarshan Pharma Industries